These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9798680

  • 1. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H, Takahashi T, Kozaki K, Yatabe Y, Mitsudomi T, Fujii Y, Sugiura T, Matsuda H, Takahashi T, Takahashi T.
    Oncogene; 1998 Oct 22; 17(16):2095-100. PubMed ID: 9798680
    [Abstract] [Full Text] [Related]

  • 2. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T.
    Oncogene; 2003 Mar 27; 22(12):1892-905. PubMed ID: 12660825
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 4. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
    Nagatake M, Osada H, Kondo M, Uchida K, Nishio M, Shimokata K, Takahashi T, Takahashi T.
    Cancer Res; 1996 Apr 15; 56(8):1886-91. PubMed ID: 8620509
    [Abstract] [Full Text] [Related]

  • 5. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
    Tsuji T, Tagawa Y, Hisamatsu T, Nakamura S, Terada R, Sawai T, Yasutake T, Ayabe H.
    Gan To Kagaku Ryoho; 1997 Jul 15; 24 Suppl 2():263-8. PubMed ID: 9263513
    [Abstract] [Full Text] [Related]

  • 6. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S.
    J Pathol; 2001 Jul 15; 194(3):318-26. PubMed ID: 11439364
    [Abstract] [Full Text] [Related]

  • 7. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V, Leprince D.
    Med Sci (Paris); 2006 Jan 15; 22(1):54-61. PubMed ID: 16386221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K.
    Cancer Res; 1993 Jan 15; 53(2):368-72. PubMed ID: 8093350
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
    Fong KM, Kida Y, Zimmerman PV, Ikenaga M, Smith PJ.
    Cancer Res; 1995 Oct 01; 55(19):4268-72. PubMed ID: 7671234
    [Abstract] [Full Text] [Related]

  • 14. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T, Nomura N, Mori H, Wake N.
    Gynecol Oncol; 1996 Nov 01; 63(2):173-9. PubMed ID: 8910623
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV, Pello MF, López-Larrea C, Suárez C, Menéndez MJ, Coto E.
    Clin Cancer Res; 1995 Sep 01; 1(9):1043-9. PubMed ID: 9816078
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
    Tsuchiya E, Tanigami A, Ishikawa Y, Nishida K, Hayashi M, Tokuchi Y, Hashimoto T, Okumura S, Tsuchiya S, Nakagawa K.
    Jpn J Cancer Res; 2000 Jun 01; 91(6):589-96. PubMed ID: 10874210
    [Abstract] [Full Text] [Related]

  • 18. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO, Lonardo F, Chang JH, Klimstra D, Rusch V, Dmitrovsky E.
    Clin Cancer Res; 2001 Feb 01; 7(2):259-66. PubMed ID: 11234877
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 20. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J, Mori N, Akiyama T, Shimosato Y, Sugimura T, Terada M.
    Princess Takamatsu Symp; 1989 Dec 01; 20():43-8. PubMed ID: 2577337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.